delirium. Delirium due to known physiological condition
Conditions
Interventions
Intervention 1: Intervention group: They receive thiamine tablets 300 mg 3 times a day (from Hakim Pharmaceutical Company) for 5 days. Intervention 2: Control group: they receive placebo tablets three
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: age > 50 y able to speak Able to provide informed consent Absence of delirium at the time of consent, as defined by the Delirium Rating Scale (ICU-CAM score > 2) Not having a previous history of neuropsychiatric disorders (dementia, Parkinson's, schizophrenia, etc.) No alcohol or drugs Absence of severe renal impairment =30GFR Absence of severe liver impairment The patient should not repent 2= APACHI
Exclusion criteria
Exclusion criteria: delirium at the time of consent, as defined by the Delirium Rating Scale (ICU-CAM score > 2) having a previous history of neuropsychiatric disorders (dementia, Parkinson's, schizophrenia, etc.) alcohol or drugs user severe renal impairment =30GFR severe liver impairment be intube APACHI <2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing the delirium score of patients hospitalized in the intensive care unit using the CAM-ICU scoring system, where a score above 2 is considered delirium. Timepoint: 5 days from the start of the medication. Method of measurement: ICU-CAM delirium scoring scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBita Akafi
Shahre-kord University of Medical Sciences
Outcome results
None listed